Open-label Extension of Study 20130173 of Denosumab in Children and Young Adults With Osteogenesis Imperfecta

Clinical trial NCT03638128 · TERMINATED

Trial details

NCT number: NCT03638128
Sponsor: Amgen
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Osteogenesis Imperfecta (OI)

Start date: 2018-07-26
Primary completion: 2022-03-28
Enrollment: 75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.